Abbott Laboratories

    Abbott Laboratories

    SSIX:ABT
    77.50
    CHF
    0.00
    (0.00%)
    35.66P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    12.7
    13.43
    13.86
    14.16
    15.71
    17.42
    18.1
    19.54
    24.42
    25.12
    23.13
    24.22
    25.53
    19.54
    Basic EPS, GAAP
    1.66
    1.51
    3
    0.95
    0.27
    1.35
    2.09
    2.54
    4.01
    3.99
    3.3
    7.74
    3.76
    2.59
    Free Cash Flow per Basic Share
    1.41
    1.72
    1.26
    1.41
    2.54
    2.79
    2.55
    3.23
    4.9
    4.49
    2.92
    3.67
    4.26
    3.35
    Dividend per Share
    0.57
    0.89
    0.98
    1.04
    1.06
    1.12
    1.29
    1.45
    1.82
    1.9
    2.05
    2.22
    2.37
    1.82
    Book Value per Share
    16.26
    14.27
    14.4
    13.94
    17.72
    17.39
    17.64
    18.51
    20.29
    21.11
    22.26
    27.52
    30.02
    - -
    Tangible Book Value per Share
    6.24
    3.49
    4.08
    5.65
    -8.37
    -6.65
    -5.18
    -3.24
    -0.1
    1.98
    3.52
    10.34
    13
    - -
    Basic Weighted Avg Shares
    1,548
    1,508
    1,473
    1,473
    1,744
    1,756
    1,763
    1,771
    1,764
    1,738
    1,734
    1,732
    1,737
    1,740
    Sales/Revenue/Turnover
    19,657
    20,247
    20,405
    20,853
    27,390
    30,578
    31,904
    34,608
    43,075
    43,653
    40,109
    41,950
    44,328
    33,992
    Operating Margin (%)
    10.85
    12.84
    14.05
    14.51
    5.71
    11.94
    14.21
    15.48
    19.56
    19.16
    16.15
    16.27
    18.17
    16.63
    Depreciation Expense
    1,719
    1,548
    1,472
    1,353
    3,021
    3,278
    3,014
    3,327
    3,538
    3,267
    3,243
    3,218
    3,116
    2,386
    Net Income, GAAP
    2,576
    2,284
    4,423
    1,400
    477
    2,368
    3,687
    4,495
    7,071
    6,933
    5,723
    13,402
    6,524
    4,497
    Effective Tax Rate (%)
    2.6
    31.65
    18.13
    24.77
    84.18
    18.76
    9.57
    10
    13.88
    16.53
    14.12
    - -
    22.94
    24.89
    Profit Margin (%)
    13.1
    11.28
    21.68
    6.71
    1.74
    7.74
    11.56
    12.99
    16.42
    15.88
    14.27
    31.95
    14.72
    13.23
    Working Capital
    9,740
    3,089
    4,969
    20,116
    11,235
    5,620
    4,804
    8,534
    11,134
    9,735
    8,829
    9,499
    9,500
    - -
    LT Debt
    3,388
    3,393
    5,871
    20,681
    27,210
    19,359
    17,416
    19,429
    18,252
    15,465
    14,548
    13,521
    10,827
    - -
    Total Equity
    25,267
    21,639
    21,326
    20,717
    31,098
    30,722
    31,301
    33,003
    36,024
    36,905
    38,827
    47,901
    52,771
    - -
    Return on Invested Capital (%)
    5.24
    5.81
    7.84
    6.23
    0.49
    5.43
    8.17
    9.4
    13.51
    12.77
    10.21
    - -
    9.56
    13.23
    Return on Capital (%)
    6.87
    7.79
    15.24
    4.72
    1.22
    5.56
    8.54
    9.7
    13.99
    13.5
    11.5
    - -
    10.66
    14.97
    Return on Common Equity (%)
    9.93
    9.78
    20.7
    6.71
    1.85
    7.71
    11.97
    14.08
    20.62
    19.13
    15.2
    31.07
    13.07
    17.79

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    ST Debt
    3,033
    4,409
    - -
    LT Borrowings
    9,896
    29,638
    - -
    LT Finance Leases
    931
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    1,737
    1,742
    1,742
    Market Capitalization
    217,036
    179,806
    160,557

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    Total Current Assets
    25,996
    25,508
    - -
    Cash, Cash Equivalents & STI
    8,939
    7,295
    - -
    Accounts Receivable, Net
    7,929
    8,210
    - -
    Inventories
    6,488
    6,989
    - -
    Total Current Liabilities
    16,496
    18,377
    - -
    Payables & Accruals
    13,463
    13,968
    - -
    ST Debt
    3,033
    4,409
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    10.37%
    10.07%
    10.17%
    Free Cash Flow
    20.29%
    9.63%
    16.44%
    Net Income, GAAP
    46.05%
    24.15%
    -51.32%
    Sales/Revenue/Turnover
    8.6%
    5.59%
    5.67%
    Total Cash Common Dividend
    11.24%
    10.21%
    7.3%

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    9,964
    10,377
    10,635
    10,974
    41,950
    2025
    10,358
    11,142
    11,369
    11,459
    44,328
    2026
    11,164
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    0.7
    0.75
    0.95
    5.33
    7.74
    2025
    0.76
    1.02
    0.95
    1.02
    3.76
    2026
    0.62
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    0.55
    0.55
    0.55
    0.55
    2.22
    2025
    0.59
    0.59
    0.59
    0.59
    2.37
    2026
    0.63
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business